US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug discovery, highlighting ...

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its ...

Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...

April 01, 2026 - PRESSADVANTAGE - As global collaboration across healthcare, biotechnology, and medical research ...

Engagement will assess KALA’s clinical assets, development options, and AI-enabled analytical opportunities, including the ...

In this edition of the biotech bi-weekly, get the latest biotech updates, including the collaboration facilitating the launch ...

Symeres, Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer: Nijmegen, Netherlands Thursday, April 2, 2026, 12:00 Hrs [IST] Symeres, a leading CRDMO ...

In the rapidly evolving field of industrial biotechnology, bacteria have emerged as crucial agents driving innovation and sustainable development.

KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript March 30, 2026 PDS Biotechnology Corporation ...